Trump says countries who were facing higher tariffs will now fall to the "baseline" tariff of 10% for at least 90 days.

Biotech has been hard hit, as one might expect, leaving many names in bargain territory. Learn why there are opportunities ...

German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact ...

Shares of major European drugmakers fell Wednesday morning after U.S. President Donald Trump reaffirmed plans to impose a ...

Fear and panic returned to the world’s stock markets today after Donald Trump’s swingeing new “Liberation Day” tariffs came ...

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the election of Barbara Weber, M.D., to its Supervisory Board, effective May 01, 2025. The ...

Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

NEW YORK CITY, NY / ACCESS Newswire / April 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

European stocks plunged sharply, and several markets tumbled to fresh multi-month lows on Friday as US President Donald Trump ...